Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma.

Hongzhi WangXianggao ZhuYuting ZhaoDezuo DongLijuan LiYong CaiYongheng LiWei-Hu Wang

Published in: BMC cancer (2022)

Registration No. ChiCTR1800018309 . Registered 11 September 2018. Retrospectively registered, https://www.chictr.org.cn/showproj.aspx?proj=30461 .

Keyphrases